Citations

1. Tabibiazar R, Edelman S (2003). Silent ischemia in people with diabetes: A condition that must be heard. Clinical Diabetes, 21(1):5–9.

2. American Diabetes Association (2007). Standards of medical care in diabetes. Clinical Practice Recommendations 2007. Diabetes Care, 30(Suppl 1): S4–S41.

3. American Diabetes Association (2004). Retinopathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S84–S87.

4. American Diabetes Association (2004). Nephropathy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S79–S83.

5. American Diabetes Association (2004). All About Diabetes. Available online: http://www.diabetes.org/about-diabetes.jsp.

6. Zochodne DW (2001). Peripheral nerve disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 466–487. Hamilton, ON: BC Decker.

7. American Diabetes Association (2004). Hypertension management in adults with diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S65–S67.

8. American Diabetes Association (2004). Preventive foot care in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S63–S64.

9. Nathan DM (2003). Isolated pancreas transplantation for type 1 diabetes. JAMA, 290(21): 2861–2863.

10. American Diabetes Association (2004). Aspirin therapy in diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S72–S73.

11. American Diabetes Association (2004). Smoking and diabetes. Clinical Practice Recommendations 2004. Diabetes Care, 27(Suppl 1): S74–S75.

12. Sigal R, et al. (2005). Prevention of cardiovascular events in diabetes, search date May 2006. Online version of Clinical Evidence (14): 1–23.

13. Sutherland DE, et al. (2001). Lessons learned from more than 1,000 pancreas transplants at a single institution. Annals of Surgery, 233(4): 463–501.

Other Works Consulted

• ACE Inhibitors in Diabetic Nephropathy Trialist Group (2001). Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Annals of Internal Medicine, 134(5): 370–379.

• Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002). Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus. JAMA, 287(19): 2563–2569.

• Gerstein HC, et al. (2001). Cardiovascular disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 488–514. Hamilton, ON: BC Decker.

• Goguen JM, Leiter LA (2001). Alternative therapy: The role of selected minerals, vitamins, fiber, and herbs in treating hyperglycemia. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 295–322. Hamilton, ON: BC Decker.

• Harvey DT (2001). Classification and risk of musculoskeletal impairment associated with diabetes. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 523–530. Hamilton, ON: BC Decker.

• Heaton JPW, et al. (2001). Erectile dysfunction. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 531–544. Hamilton, ON: BC Decker.

• Ludwig DS (2002). The glycemic index: Physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA, 287(18): 2414–2423.

• Pickup J, Keen H (2002). Continuous subcutaneous insulin infusion at 25 years. Diabetes Care, 25(30): 593–598.

• Steele AW (2001). Kidney disease. In HC Gerstein, RB Haynes, eds., Evidence-Based Diabetes Care, pp. 429–465. Hamilton, ON: BC Decker.